UBS AM’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
295,061
+111,659
| +61% | +$726K | ﹤0.01% | 2160 |
|
|
2025
Q1 | $1.48M | Buy |
183,402
+18,164
| +11% | +$147K | ﹤0.01% | 2139 |
|
|
2024
Q4 | $2.04M | Buy |
165,238
+20,520
| +14% | +$254K | ﹤0.01% | 2034 |
|
|
2024
Q3 | $1.19M | Sell |
144,718
-26,331
| -15% | -$216K | ﹤0.01% | 2311 |
|
|
2024
Q2 | $854K | Buy |
171,049
+95,996
| +128% | +$479K | ﹤0.01% | 2454 |
|
|
2024
Q1 | $463K | Buy |
75,053
+18,027
| +32% | +$111K | ﹤0.01% | 2309 |
|
|
2023
Q4 | $288K | Buy |
+57,026
| New | +$288K | ﹤0.01% | 2425 |
|
|
2021
Q2 | – | Sell |
-22,605
| Closed | -$127K | – | 2784 |
|
|
2021
Q1 | $127K | Sell |
22,605
-12,146
| -35% | -$68.1K | ﹤0.01% | 2585 |
|
|
2020
Q4 | $273K | Buy |
34,751
+8,863
| +34% | +$69.8K | ﹤0.01% | 2431 |
|
|
2020
Q3 | $220K | Buy |
25,888
+2,596
| +11% | +$22K | ﹤0.01% | 2383 |
|
|
2020
Q2 | $242K | Buy |
+23,292
| New | +$242K | ﹤0.01% | 2340 |
|
|
2019
Q3 | – | Sell |
-8,507
| Closed | -$222K | – | 2905 |
|
|
2019
Q2 | $222K | Sell |
8,507
-134,301
| -94% | -$3.5M | ﹤0.01% | 2510 |
|
|
2019
Q1 | $5.55M | Buy |
142,808
+4,707
| +3% | +$183K | ﹤0.01% | 1112 |
|
|
2018
Q4 | $5.81M | Sell |
138,101
-12,318
| -8% | -$518K | 0.01% | 1042 |
|
|
2018
Q3 | $7.52M | Buy |
150,419
+5,477
| +4% | +$274K | 0.01% | 1009 |
|
|
2018
Q2 | $5.54M | Buy |
+144,942
| New | +$5.54M | ﹤0.01% | 1116 |
|